Correlation Between Sarepta Therapeutics and Indaptus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Indaptus Therapeutics, you can compare the effects of market volatilities on Sarepta Therapeutics and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Indaptus Therapeutics.
Diversification Opportunities for Sarepta Therapeutics and Indaptus Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Sarepta and Indaptus is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Indaptus Therapeutics go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and Indaptus Therapeutics
Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 0.57 times more return on investment than Indaptus Therapeutics. However, Sarepta Therapeutics is 1.74 times less risky than Indaptus Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Indaptus Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 9,393 in Sarepta Therapeutics on September 13, 2024 and sell it today you would earn a total of 3,146 from holding Sarepta Therapeutics or generate 33.49% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sarepta Therapeutics vs. Indaptus Therapeutics
Performance |
Timeline |
Sarepta Therapeutics |
Indaptus Therapeutics |
Sarepta Therapeutics and Indaptus Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sarepta Therapeutics and Indaptus Therapeutics
The main advantage of trading using opposite Sarepta Therapeutics and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Indaptus Therapeutics vs. Puma Biotechnology | Indaptus Therapeutics vs. Iovance Biotherapeutics | Indaptus Therapeutics vs. Sarepta Therapeutics | Indaptus Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |